Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma

Clinical trial NCT07302919 · RECRUITING

Trial details

NCT number: NCT07302919
Sponsor: University Hospital, Basel, Switzerland
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hepato Cellular Carcinoma (HCC)

Start date: 2026-02-16
Primary completion: 2028-06-01
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.